MASSACHUSETTS
BIOMEDICAL
INITIATIVES
MBI is a nonprofit building a biotech cluster in Central Massachusetts. We help emerging life sciences companies advance from concept to clinical trials, create jobs, and promote economic development.
Incubate
We help emerging life sciences companies advance from concept to clinical trials so they can bring lifesaving products to patients
Companies
Since 2000, MBI has incubated over 188 companies that have created over 1,800 jobs and raised over $1.4 billion
Cluster Building
We support economic and workforce development to create a sustainable ecosystem in Massachusetts
Success Stories
TransCode Therapeutics
A platform delivery company focusing on oncology, TransCode launched clinical trials while at MBI. The team closed a $30M IPO event while at our incubator and announced an additional $7M IPO shortly after graduating in 2023.
iVexSol
iVexSol, whose mission is to improve patients' lives by developing transformative vector production technologies, graduated from MBI in 2022 with 20+ employees and has raised $40M to date.
Invetx
A veterinary therapeutics company focused on biopharmaceuticals that bring the best of human biotechnology to animal health, Invetx graduated from MBI in 2022 and has raised over $80M+.
featured news
Auxilium and MBI Announce First Accelerator Cohort, Investing $1 Million Across Four Life Science and Healthcare Startups
Auxilium and MBI today announced the inaugural cohort of the Auxilium-MBI Accelerator, investing $1 million across four life sciences and healthcare startups as part of an effort to accelerate startup growth and strengthen the Central Massachusetts ecosystem. Through the program, Auxilium will invest a total of $1 million across the cohort, with each company receiving a $250,000 investment to help accelerate growth beyond early validation.
latest updates
Massachusetts Biomedical Initiatives (MBI) Announces Auxilium-MBI Accelerator Cohort and Expands Regional Life Sciences Ecosystem with New Companies and Strategic Partnerships in Second Quarter of 2026
MBI's second quarter of 2026 marked continued growth for Central Massachusetts' life sciences ecosystem, with the launch of the Auxilium-MBI Accelerator, new incubator companies, SPARK program graduates, strategic partnerships, and investments supporting the region's expanding biomanufacturing sector.